Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|January 8, 2013
[Ventilation abnormalities in systolic and diastolic left ventricular dysfunction]Andrzej Kułach, Robert Swiderski, Klaudia Gieszczyk, et al.
Cardiology Journal|November 24, 2017
Severe degenerative aortic stenosis with preserved ejection fraction does not change adipokines serum levelsKatarzyna Mizia-Stec, Tomasz Bochenek, Błażej Kusz, et al.
Pharmacological Reports : PR|April 9, 2013
Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarctionMaciej Haberka, Katarzyna Mizia-Stec, Magdalena Mizia, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 14, 2010
N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarctionMaciej Haberka, Katarzyna Mizia-Stec, Magdalena Mizia, et al.
Scientific Reports|October 2, 2021
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosisKlaudia Gieszczyk-Strózik, Maciej T Wybraniec, Małgorzata Widuchowska, et al.
Kardiologia Polska|October 19, 2011
B-cell lymphoma in a 70 year-old male patient with a cardiac tumourKatarzyna Mizia-Stec, Maciej Haberka, Patryk Grzywocz, et al.
Archives of Medical Science : AMS|February 1, 2012
N-3 Polyunsaturated fatty acid therapy improves endothelial function and affects adiponectin and resistin balance in the first month after myocardial infarctionKatarzyna Mizia-Stec, Maciej Haberka, Magdalena Mizia, et al.
Cardiology Journal|January 29, 2014
N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary interventionKatarzyna Mizia-Stec, Magdalena Mizia, Maciej Haberka, et al.
Kardiologia Polska|December 3, 2013
Flow-mediated dilatation (FMD) and prevalence of cardiovascular risk factors: the value of FMD assessment in high risk patients is limitedKatarzyna Mizia-Stec, Joanna Wieczorek, Michał Orszulak, et al.
Pharmacological Reports : PR|June 5, 2012
Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary interventionKatarzyna Mizia-Stec, Maciej Haberka, Magdalena Mizia, et al.
Pageof 2